(Q37489935)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Excitatory amino acid transporters as potential drug targets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Anders A Jensen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Mette N Erichsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

719-731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19456273%20AND%20SRC:MED&resulttype=core&format=json

Excitatory Amino Acid Neurotoxicity

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Molecular targets in cerebral ischemia for developing novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

New therapeutic frontiers for metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Ionotropic glutamate receptors & CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate receptor function in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate as a therapeutic target in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The role of glutamate and its receptors in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Neuropathic pain: emerging treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate- and GABA-based CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Ligands for glutamate receptors: design and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Subtype selective kainic acid receptor agonists: discovery and approaches to rational design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Structure-activity relationships of selective GABA uptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century--a medicinal chemistry survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Gate movements in glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Structure of a glutamate transporter homologue from Pyrococcus horikoshii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Flux coupling in a neuronal glutamate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Voltage-independent sodium-binding events reported by the 4B-4C loop in the human glutamate transporter excitatory amino acid transporter 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

An excitatory amino-acid transporter with properties of a ligand-gated chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Trimeric Subunit Stoichiometry of the Glutamate Transporters from Bacillus caldotenax and Bacillus stearothermophilus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

A trimeric quaternary structure is conserved in bacterial and human glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate transporters: animal models to neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Distribution of glutamate transporter subtypes during human brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Neuronal glutamate transporter EAAT4 is expressed in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Differential synaptic localization of GluR2 and EAAC1 in the macaque monkey entorhinal cortex: a postembedding immunogold study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Plasma membrane monoamine transporters: structure, regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

High-affinity Na+/K+-dependent glutamate transporter EAAT4 is expressed throughout the rat fore- and midbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Clearance of glutamate inside the synapse and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Localization of neuronal and glial glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reupta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

WAY‐855 (3‐amino‐tricyclo[2.2.1.02.6]heptane‐1,3‐dicarboxylic acid): a novel, EAAT2‐preferring, nonsubstrate inhibitor of high‐affinity glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Translational Control of Glial Glutamate Transporter EAAT2 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Alphaxalone, a neurosteroid anaesthetic, increases the activity of the glutamate transporter type 3 expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Effects of propofol on the activity of rat glutamate transporter type 3 expressed in Xenopus oocytes: the role of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Propofol reverses oxidative stress-attenuated glutamate transporter EAAT3 activity: evidence of protein kinase C involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The pipeline and future of drug development in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Molecular targets for treating cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Regulation of neuronal glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Antidepressant-like effects of ceftriaxone in male C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

The neuroprotective agent MS-153 stimulates glutamate uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127

Nicergoline enhances glutamate uptake via glutamate transporters in rat cortical synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220902926127